Home / News / India News / Article /
DCGI grants permission to Bharat Biotech to conduct Covaxin trial on 2-18 age group
Updated On: 13 May, 2021 11:54 AM IST | New Delhi | mid-day online correspondent
The trial will take place at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
Photo used for representational purpose. Pic/AFP
The Drug Controller General of India (DCGI) on Thursday gave permission to Bharat Biotech to conduct clinical trials of Covaxin on those aged between two to 18 years, Union Health Ministry said on Thursday.
The decision comes after Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organization (CDSCO) recommended Covaxin for phase II/III clinical trial on those aged between two to 18 years.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT